April 01, 1999; 52 (7) Article
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III)
First published April 1, 1999, DOI: https://doi.org/10.1212/WNL.52.7.1427
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III)
Neurology Apr 1999, 52 (7) 1427; DOI: 10.1212/WNL.52.7.1427
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 52 no. 7 1427
PubMed:
Print ISSN:
Online ISSN:
History:
- Received March 16, 1998
- Accepted in final form January 9, 1999
- First Published April 1, 1999.
Copyright & Usage:
© 1999
Author Disclosures
- Address correspondence and reprint requests to Dr. Walter G. Bradley, Department of Neurology (D4-5), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
New approaches to the treatment of ALSRobert G. Miller, Robert Sufit et al.Neurology, April 01, 1997 -
Articles
A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosisALS CNTF Treatment Study Group et al.Neurology, May 01, 1996 -
Clinical Trials and Future Research
Clinical trials of riluzole in patients with ALSR. G. Miller, J. P. Bouchard, P. Duquette et al.Neurology, October 01, 1996 -
Articles
Clinical evaluation of ALS drugsBenjamin Rix Brooks et al.Neurology, April 01, 1997